CUSIP: 126650100
Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,268,585,398
-
Total 13F shares
-
1,019,162,974
-
Share change
-
+21,029,174
-
Total reported value
-
$60,179,918,934
-
Put/Call ratio
-
79%
-
Price per share
-
$59.06
-
Number of holders
-
1,883
-
Value change
-
+$1,060,433,822
-
Number of buys
-
655
-
Number of sells
-
1,401
Quarterly Holders Quick Answers
What is CUSIP 126650100?
CUSIP 126650100 identifies CVS - CVS HEALTH Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2024
-
Previous quarter:
Q1 2024
Recent filing periods for CUSIP 126650100:
Institutional Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q2 2024
As of 30 Jun 2024,
CVS HEALTH Corp - Common Stock (CVS) was held by
1,883 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,019,162,974 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Dodge & Cox, Capital World Investors, STATE STREET CORP, Capital Research Global Investors, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and Capital International Investors.
This page lists
1,888
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.